Inhaled Surfactant Therapy in Newborns in Artificial Lung Ventilation
Objective: to evaluate the efficiency of inhaled surfactant therapy in neonatal infants with respiratory failure.Subjects and methods. The trial enrolled 13 premature neonatal infants; their mean gestational age was 31.8±2.8 weeks and the birth weight was 1825±600.9 g. They had a oneminute Apgar sco...
Main Authors: | S. A. Perepelitsa, A. A. Luchina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Medical Sciences
2014-10-01
|
Series: | Obŝaâ Reanimatologiâ |
Subjects: | |
Online Access: | https://www.reanimatology.com/rmt/article/view/1420 |
Similar Items
-
The clinical and microbiological efficacy of vancomycin in the combination treatment of newborns with ventilator-associated pneumonia caused by gram-positive cocci
by: M. V. Kushnareva, et al.
Published: (2016-03-01) -
Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps
by: Daniele De Luca, et al.
Published: (2021-02-01) -
The Results of Bacteriological Examination in Premature Infants with Neonatal Morbidity and Mortality
by: Agamurad A. Orazmuradov, et al.
Published: (2020-12-01) -
Effects of surfactants on preterm infant lungs
by: Gian Maria Pacifici -
Comparison of the Efficacy of Three Natural Surfactants in Preterm Turkish Newborns with Respiratory Distress Syndrome
by: Fatma Hilal Yılmaz, et al.
Published: (2021-06-01)